AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NOVARTIS' drug Femara, designed to treat early-stage breast cancer, received FDA approval. In trials, Femara reduced death rates by 39%.
NAM TAI ELECTRONICS earned 24 cents a share ex items in Q3, up 14% but 2 cents under views. The electronics manufacturer forecast Q4 of 21-23 cents a share, also below analysts' projections. Shares fell 9%.
ING said the NASD may recommend disciplinary action against its U.S. affiliate. Shares in the Dutch ...